<- Back to digest

Archives of Orthopaedic and Trauma Surgery - 2026-08-20 - Journal Article; Systematic Review; Meta-Analysis; Review

The effect of surgeon volume on outcomes after total hip arthroplasty: a systematic review and meta-analysis.

Meissner N, Ortwig K, Ramos-Pascual S, Agu C, Stoeve J, Schrednitzki D, Rolvien T, Halder AM

meta-analysisLOE IIn = 18 studies, 796,061 patientsOutcomes assessed at 1 month, 3 months, and 12 months; no long-term follow-up reported.

Topics

arthroplasty
PMID: 42622668DOI: 10.1007/s00402-026-06434-wView on PubMed ->

Key Takeaway

High-volume THA surgeons had significantly lower 1-month readmission (OR 1.6, p=0.033) and 3-month mortality (OR 1.8, p=0.008) compared to low-volume surgeons, but revision rates at 3 and 12 months were not significantly different across 796,061 patients.

Summary Depth

Choose how much analysis to show on this article page.

Summary

This PRISMA-registered systematic review and meta-analysis compared outcomes of primary THA performed by low- vs. high-volume surgeons across 18 studies and 796,061 patients. High-volume surgeons demonstrated significantly lower 1-month readmission (OR 1.6, p=0.033) and 3-month mortality (OR 1.8, p=0.008), but no significant differences were found for 3-month or 12-month revision rates (OR 2.0 and 1.8, respectively; both p=0.228). A critical methodological finding was that 11 of 18 studies used arbitrary thresholds to define high vs. low volume, limiting cross-study comparability.

Key Limitation

The absence of a standardized, evidence-based definition of 'high-volume' surgeon across included studies makes the pooled ORs difficult to translate into actionable case-volume thresholds for credentialing or policy.

Original Abstract

PURPOSE

To synthesize, critically appraise and systematically review studies comparing outcomes after primary total hip arthroplasty (THA) performed by low- vs. high-volume surgeons, and to propose evidence-based threshold definitions for these categories.

METHODS

This review followed the PRISMA guidelines and was registered in PROSPERO. Medline and Embase were searched on March 24, 2025. Prospective and retrospective clinical studies were included if they reported THA thresholds for low- and high-volume surgeons. Articles not written in English or German were excluded. Outcomes were pooled and presented in forest plots. Methodological quality was assessed.

RESULTS

Of 872 identified articles, 18 were included, reporting on 796,061 patients undergoing THA. Methodological quality was high in all studies (>6 of 7 points). Thresholds used to define high- vs. low-volume were determined using arbitrary values (n = 11), tertiles (n = 1), quartiles (n = 3), percentiles (n = 2), or receiver operating characteristic curves (n = 1). High-volume surgeons had significantly lower 1-month readmission rates [odds ratio (OR) = 1.6; p = 0.033] and 3-month mortality rates (OR = 1.8; p = 0.008). In contrast, there were no significant differences between high- and low-volume surgeons for 3-month revision rates (OR = 2.0; p = 0.228), 12-month revision rates (OR = 1.8; p = 0.228), and 3-month readmission rates (OR = 1.3; p = 0.337).

CONCLUSIONS

The included studies demonstrated considerable variability in the definitions of surgeon volume. However, there remains a trend suggesting that higher-volume surgeons experience fewer revisions, complications, readmissions, and mortality; although these differences were largely not statistically significant. Nonetheless, surgeon volume may not be the only factor influencing outcomes, as hospital and patient characteristics may influence short- to long-term outcomes following primary THA.